Drug Shortage Report for MYLAN-LAMOTRIGINE
Report ID | 130881 |
Drug Identification Number | 02265516 |
Brand name | MYLAN-LAMOTRIGINE |
Common or Proper name | LAMOTRIGINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | LAMOTRIGINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2020-12-10 |
Estimated end date | 2021-04-20 |
Actual end date | 2021-04-21 |
Shortage status | Resolved |
Updated date | 2021-04-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2021-04-22 | English | Compare |
v12 | 2021-04-21 | French | Compare |
v11 | 2021-04-21 | English | Compare |
v10 | 2021-04-20 | French | Compare |
v9 | 2021-04-20 | English | Compare |
v8 | 2021-04-13 | French | Compare |
v7 | 2021-04-13 | English | Compare |
v6 | 2021-03-17 | French | Compare |
v5 | 2021-03-17 | English | Compare |
v4 | 2021-01-12 | French | Compare |
v3 | 2021-01-12 | English | Compare |
v2 | 2021-01-05 | French | Compare |
v1 | 2021-01-05 | English | Compare |
Showing 1 to 13 of 13